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Abstract A Hirudo medicinalis cDNA isolated from regener-
ating CNS tissue at 24 h post-axotomy was identi¢ed as a leech
homologue of the mammalian cysteine-rich intestinal proteins
(CRIPs) and named HmCRIP. HmCRIP is up-regulated within
6 h of axotomy, peaking at 24 h. This is the ¢rst demonstration
of a CRIP homologue in regenerating CNS and in a serotoner-
gic neurone. In rodents CRIP is an important factor in the
regulation of the in£ammatory immune response through con-
trol of Th1/Th2 di¡erentiation. The role of HmCRIP in the
regeneration competent environment of the annelid central ner-
vous system is discussed.
/ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Following trauma or experimental axotomy neurones in the
mammalian central nervous system (CNS) do not regenerate,
and their failure to reconnect to appropriate target cells leads
to loss of function [1]. The devastating e¡ects of traumatic
spinal cord injury and brain damage have focussed attention
on the mechanisms underlying the failure of CNS to repair. In
contrast to CNS neurones, peripheral nervous system (PNS)
neurones in mammals are able to regenerate. A comparison of
the regenerative abilities of CNS and PNS neurones and the
demonstration that CNS neurones will extend new processes
when presented with a PNS graft [2,3] have led to the identi-
¢cation of factors in the glial microenvironment of damaged
CNS neurones that are inhibitory for neurite outgrowth [4^7].
An alternative strategy for understanding nervous system
repair is to study the molecular basis for successful repair in
an animal whose CNS is regeneration competent. The leech
Hirudo medicinalis has an impressive ability to repair damage
to its CNS, and the ability of individual axotomised CNS
neurones to survive injury, regrow processes and reform spe-
ci¢c synaptic connections to restore function is well docu-
mented [8,9]. We have used identi¢ed neurones in this model
organism to characterise the molecular events that follow
nerve cell damage by isolating genes whose expression is al-
tered following injury [10^12]. A serotonergic neurone cDNA
library was screened using subtracted radiolabelled probes
that we produced from regenerating and non-regenerating
ganglia of leech CNS. This screen has demonstrated that
a homologue of a human cysteine-rich intestinal protein
(CRIP), HmCRIP (AY156993), is up-regulated following ax-
otomy and is expressed in a serotonergic neurone. Quantita-
tive analysis shows that HmCRIP is up-regulated by 6 h post-
axotomy; its expression peaks at 24 h and remains at elevated
levels up to 72 h post-axotomy. The CRIPs in mammals are
involved with the modulation of the immune system. Their
potential role in axotomy and regeneration is discussed.
2. Materials and methods
2.1. Subtracted probe production
Leeches (Ricarimpex, France) were anaesthetised in 0.2% chlorobu-
tanol (Sigma), and the ninth ganglia axotomised as described previ-
ously [10,13]. Fifty ng of total RNA from ganglia at 0 and 24 h post-
axotomy were used to produce cDNA using the SMART PCR cDNA
synthesis kit (Clontech). Two rounds of forward and reverse subtrac-
tive hybridisation were conducted following manufacturer’s protocols
(cDNA Subtraction Kit, Clontech) to produce two cDNA probes,
‘control’ (transcripts enriched in non-axotomised ganglia) and ‘24 h’
(transcripts enriched in regenerating ganglia).
2.2. Identi¢cation of di¡erentially expressed genes
Twenty-¢ve ng of each probe was radiolabelled with [K-32P]dCTP
to approximately equal speci¢c activity using High Prime (Boehr-
inger). A total of 1.25U105 pfu of an identi¢ed neurone (Retzius
cell) library (Wang et al., in preparation) was screened following stan-
dard protocols [14]. Duplicate ¢lter lifts of the library were hybridised
with the subtracted probes at 65‡C in Denhardts based bu¡er [14].
The ¢lters were washed to 0.1USSC, 0.1% SDS and exposed to X-ray
¢lm. Di¡erentially expressed clones were isolated by comparing the
hybridisation seen to each duplicate ¢lter when probed with either
control or 24 h cDNA. Clones of interest were excised as double
stranded plasmids and sequenced using an ABI £uorescent sequencer.
2.3. Semi-quantitative analysis of gene expression following injury
Plasmids containing either HmCRIP or leech Elongation Factor
1-K (accession no. AAC03162) were PCR ampli¢ed using M13 and
M13rev primers that £ank the multiple cloning site of the vector.
Amplicons were puri¢ed and diluted to a concentration of 100 ng
Wl31. One Wl of this cDNA was spotted in duplicate on four individual
nylon ¢lters. The ¢lters were then hybridised at 65‡C with 32P radio-
labelled ¢rst strand cDNA probes produced as follows. The ninth
segmental ganglia from ¢ve leeches was collected at each of the fol-
lowing time points: 0, 6, 24 and 72 h post-axotomy. RNA was iso-
lated using the RNAqueous-4PCR extraction kit (Ambion, Austin,
TX, USA). First strand cDNA was produced using SuperScript II
reverse transcriptase whilst incorporating 1 Wl of [32P]dCTP (10 mCi
ml31) to radiolabel the probes to high speci¢city. Probes were hybrid-
ised at 65‡C overnight then washed to 0.1USSC, 0.1% SDS. Hybrid-
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isation intensity was quanti¢ed using the NIH IMAGE analysis pack-
age. Semi-quantitive data were obtained by comparison of the
HmCRIP with an endogenous control gene leech Elongation Factor
1-K.
2.4. Sequence and phylogenetic analysis
The nucleotide sequence of HmCRIP was used to search the ‘nr’
database at NCBI using the BLASTx algorithm [15]. The conceptual
ORF was obtained by translation of the nucleotide sequence in all six
reading frames using the translate tool at Expasy (http://www.expa-
sy.ch/) [16]. CRIP orthologues were detected using the tBLASTn op-
tion of the BLAST algorithm to search the EST_others database
(non-human, non-mouse ESTs) at the NCBI. Conceptual translations
of the ESTs were produced as above. The boundaries of individual
LIM domain were determined using the SMART programme (http://
www.smart.ox.ac.uk) [17] and the sequences trimmed to this region
alone. The two LIM domains of human CSR2 (accession no. Q16527)
[26], mouse CRP2 (accession NP_031818. 1) [27], the three LIM do-
mains from Schizosaccharomyces pombe Leupaxin-like LIM domain
protein (accession no. O74398) and two LIM domains from S. pombe
GTPase-activator protein for Rho-like GTPase (accession no.
O14014) [28] were also aligned. In each of these cases the numbering
starts with the most N-terminal LIM domain. The LIM domain se-
quences were ¢rst aligned and boot strap values based on 1000 trials
were calculated using Clustal-X [18]. Phylogenetic analysis was visual-
ised using NJ-plot [19]. The Clustal-X alignments were coloured using
the CHROMA programme [20].
3. Results
A clone of 360 bp identi¢ed as being up-regulated at 24 h
post-axotomy was isolated from the Retzius library screen.
The cDNA encoded a 78 amino acid glycine and lysine-rich
protein. Using the BLASTx algorithm the highest scoring pair
(E=7U10335) to the leech sequence was human cysteine-rich
intestinal protein 1 (CRIP1, accession NP_001302) [21]. The
leech clone was named H. medicinalis HmCRIP. Analysis of
the HmCRIP protein using SMART showed that, like the
human, rat and mouse CRIP’s [22,23] the HmCRIP contains
a single zinc-binding LIM domain. The translated HmCRIP
amino acid sequence was used in a BLASTP search which
isolated many proteins with high similarity to the LIM do-
main, but many were not true CRIP proteins. In order to
identify potential HmCRIP orthologues other than the previ-
ously identi¢ed human, rat and mouse CRIPs, a search of the
non-human, non-mouse, EST database at the NCBI was ini-
tiated. One hundred and eighty-three previously uncharac-
terised potential CRIP EST’s from 28 di¡erent species were
identi¢ed. Of these 28 species, 13 were from the Phylum
Nematoda, one from the Arthropoda, one from the Annelida
and 13 from the Chordata. Representative transcripts from
each of the species were translated to amino acid sequence
and the open reading frames aligned using Clustal-X. Repre-
sentative mouse and human CRIP sequences were also in-
cluded in the subsequent analysis. Fig. 1 shows a coloured
alignment of potential CRIP orthologues. A high degree of
similarity is seen across the di¡erent phyla. We note that the
nematode sequences have two additional residues located be-
tween the ¢fth and sixth cysteines of the LIM domain, and
also lack a conserved proline residue (Fig. 1). How this a¡ects
the binding of the zinc-¢nger domain is unknown. In addition
to the high degree of similarity, the genes were considered
HmCRIP orthologues because all conceptual open reading
frames were of similar length (78^109 amino acids) and the
C-terminal £anking region follows the consensus for the hu-
man CRIP glycine-rich region [23,24]. The previously charac-
terised CRIP proteins are human, rat and mouse, although
chicken, ¢sh (Lebistes reticularis) and sea squirt (Botryllus
schosseri) DNA has been shown to hybridise to a rat CRIP
probe [22]. A Caenorhabditis elegans gene (accession no.
Fig. 1. Clustal-X alignment of the newly identi¢ed CRIP proteins. Conserved zinc-binding cysteine and histidine residues are highlighted with
an asterix. The nematode speci¢c di¡erences are marked 3. The conserved LIM domain sequence ((F/Y)GPKG) [23] is marked with a bar. Ac-
cession numbers for each of the sequences are given in parentheses. The alignment was coloured using the CHROMA programme [20].
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AAA28023) has been annotated as a homologue of CRIP.
Analysis using the SMART programme showed that this pro-
tein also contained Nebulin domains which bind actin [25]
and a transmembrane domain. Thus AA28023 is a LIM do-
main containing protein, but not a CRIP orthologue. The
newly discovered C. elegans EST (accession AV194330) may
prove useful as an invertebrate model for study of the func-
tion of CRIP.
To investigate the evolutionary relationship of the new
CRIP orthologues, the LIM domain from these 28 species
plus human and mouse CRIP were aligned. The resulting
phylogenetic tree shows that the proteins generally group ac-
cording to taxonomic relationships, with the CRIP LIM do-
mains separate from the non-CRIP LIM domain proteins
(Fig. 2). This suggests that during the evolutionary history
of the LIM domain, a domain duplication event produced
the multiple LIM domain proteins from an ancestral protein
with a single LIM domain, and that this ancestral form has
subsequently been lost from certain phyla.
The isolation of HmCRIP identi¢ed the clone as being up-
regulated at 24 h post-axotomy. We subsequently analysed
expression of the gene between 0 and 72 h post-axotomy.
Semi-quantitative analysis of gene expression (Fig. 3) showed
that up-regulation of HmCRIP could be detected at 6 h post-
axotomy, when the level of expression was approximately
three times greater than at time zero. The expression peaked
at 24 h with levels approximately ¢ve times those at time zero,
but dropped to nearly pre-axotomy levels by 72 h. As Hm-
CRIP was identi¢ed in the serotonergic neurone (Retzius cell)
library it would be interesting to determine if this speci¢c
neurone responds following injury. In in situ hybridisation
experiments on leech ganglia, digoxigenin-labelled HmCRIP
probes positively labelled many cells in addition to the Retzius
cells (results not shown). Since digoxygenin-labelled probes do
not give reliable quantitative data, future work will study the
expression of HmCRIP by individual cells following injury
using quantitative RT-PCR to determine whether di¡erent
cells types di¡erentially express HmCRIP in response to in-
jury.
4. Discussion
The CRIPs are small zinc-binding proteins containing a
single LIM domain [29]. The LIM domain comprises of a
double zinc ¢nger of the consensus sequence: C-X2-C-X16-
23-(HCD)-X2-(CEH)-X2-C-X2-C-X16-21-C-X2-3-(CHD). It
was ¢rst described in a set of three transcription factors
Lin-11, Isl-1 and Mec-3, from which the name was derived
[30^32]. Due to the plethora of proteins containing the LIM
domain, schemes have been proposed to classify them into
three groups [33]. Although the LIM homeodomain protein
is abundant in developing CNS and is thought to confer mo-
tor neurone identity [34], as far as we are aware this is the ¢rst
Fig. 2. Phylogenetic analysis of the LIM domains of identi¢ed
CRIP proteins. Sequences were aligned using Clustal-X, bootstrap
values are based on 1000 trials, bootstrap values greater than 50%
are shown. The tree was produced using NJ-plot. LIM_RAs_n_S.-
pombe=S. pombe GTPAse activator protein (accession no.
O14014), LIM_n_S.pombe=S. pombe Leupaxin protein (accession
no. O74398), CRP2_M.musculus =M. musculus CRP2 (accession no.
NP_031818. 1) and CSR2_H.spapiens=H. sapiens CSR2 protein
(accession no. Q16527). n=LIM domain number as described in
Section 2.
Fig. 3. Semi-quantitative gene expression dot blot. Nitrocellulose ¢l-
ters were dotted with duplicate spots of HmCRIP and leech Elonga-
tion Factor 1-K. The ¢lters were probed with radiolabelled cDNA
produced from ¢ve ganglia at appropriate time points. Activity was
measured by densitomic analysis of exposed X-ray ¢lm (panel A).
Relative abundance (panel B) was calculated as a ratio of HmCRIP
expression to Elongation Factor 1-K (ELF-1K). Error bars represent
one standard deviation.
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demonstration that a LIM-only CRIP mRNA is expressed in
regenerating CNS and in an identi¢ed nerve cell.
The CRIP1 protein was ¢rst described as an intestinal
marker for the suckling-to-weaning transition in mice and
rats [22]. However, our analysis has identi¢ed a much wider
ranging taxonomic distribution than previously thought, en-
compassing the phyla Chordata, Arthropoda, Nematoda and
Annelida. The LIM domain is wide spread in the Metazoa,
Fungi and Viridiplantae kingdoms, but could not be detected
in the Eubacteria or Archaea. The domain is therefore a rel-
atively ancient structure that evolved after the divergence of
the eukaryotes. Our phylogenetic analysis showed that the
corresponding LIM domains of di¡erent proteins are more
similar than two LIM domains within a single protein. This
complements the ¢ndings of Tsui et al. [23], who compared
the human cysteine-rich heart protein with rat CRIP.
Much work has focused on the role of the LIM domain as a
mediator of protein^protein interaction [35^37], and on the
LIM homeodomain proteins which are known to be impor-
tant for cell fate speci¢cation and development [34,37]. The
presence of the LIM domain led to CRIP being thought of as
a protein that plays a role in the regulation of growth and
di¡erentiation of eukaryotic cells. The human form of CRIP
is highly expressed in peripheral immune cells and over-ex-
pression of CRIP in transgenic mice modulates the expression
of Th1/Th2 cytokines [38^40]. This immunological role for
CRIP ¢ts well with its high expression in the intestine [41],
a well-established site of host protection and immunity [42].
How does a proposed immunological function ¢t with our
¢ndings of up-regulation of CRIP following nerve cell injury
in the leech? The invertebrates are not thought to possess
adaptive immune defence systems which rely on the posses-
sion of lymphocytes and antibodies [43]. However cytokine-
like molecules have been characterised in the invertebrates
[44,45]. A solution to this apparent anomaly has been pro-
posed by Beschin et al. [46,47], who show that vertebrate and
invertebrate cytokine-like molecules have evolved through
convergent evolution, sharing similar structures, but are not
homologous proteins, as is evident when analysed at the ami-
no acid level. CRIP is di¡erent in this respect in that the
amino acid sequences are highly conserved and HmCRIP
and CRIP are certainly homologues.
As HmCRIP mRNA expression increases following CNS
injury what cells could this signalling protein be a¡ecting?
Annelids possesses macrophage-like and natural-killer-like
cells [48,49], and these cells become activated and show exten-
sive migration following injury [50]. Could such cells be re-
sponding to damage response proteins such as HmCRIP? If
pro-in£ammatory signals are used to stimulate the activation
and migration of these cell types, then one might predict that
counter, anti-in£ammatory control mechanisms also exist. It
has been suggested that in£ammatory and ‘auto-immune’-like
reactions following human injury lead to more damage than
the original trauma [51]. The progression of conditions such
as multiple sclerosis and experimental autoimmune encepha-
litis are thought to be moderated by the immune environment,
such that pro-in£ammatory Th1 type cytokines induce dam-
aging autoimmune reactions, which can be reduced by the
induction of a Th2 anti-in£ammatory environment [52]. This
Th1/Th2 modulatory role has been suggested for CRIP in
rodents. The high degree of similarity between the leech and
the human/mouse CRIPs would suggest that strong evolution-
ary forces have acted to maintain the function of the protein
from annelids to mammals. HmCRIP is therefore a good
candidate for a molecular switch controlling an invertebrate
pro/anti-in£ammatory response following injury.
A rapid expression of HmCRIP following injury (within 6
h) and a decline at 72 h post-axotomy would allow temporal
regulation of the immune response following injury. If high
levels of HmCRIP act to modulate the immune system as in
rodents then an anti-in£ammatory environment would be in-
duced following axotomy, which may reduce cellular damage
and promote regeneration.
The isolation of HmCRIP from the annelid H. medicinalis
and the subsequent identi¢cation of orthologous genes in oth-
er invertebrate species, which are not thought to possess an
adaptive immune system, is of interest from an evolutionary
perspective. These ¢ndings suggest that either CRIP has an
alternate role in the invertebrate species, or as we propose,
that CRIP is an ancient gene expressed following cell damage
which has been sequestered into the immune response reper-
toire of the chordates.
It would be of interest to follow the expression of CRIP
following CNS injury in a mammalian species. This may shed
light on the role of immune modulation in response to cellular
insult, and how the control of the microenvironment a¡ects
capacity for CNS regeneration.
Acknowledgements: Supported by the Medical Research Council UK
and The Human Frontiers Science Programme. We thank Chris Pont-
ing for helpful advice and discussions.
References
[1] Fry, E.J. (2001) Clin. Exp. Pharmacol. Physiol. 28, 253^258.
[2] David, S. and Aguayo, A.J. (1981) Science 214, 931^933.
[3] David, S. and Aguayo, A.J. (1985) J. Neurocytol. 14, 1^12.
[4] Huber, A.B. and Schwab, M.E. (2000) Biol. Chem. 381, 407^
419.
[5] Grandpre, T. and Strittmatter, S.M. (2001) Neuroscientist 7,
377^386.
[6] Caroni, P. and Schwab, M.E. (1988) J. Cell Biol. 106, 1281^1288.
[7] Caroni, P. and Schwab, M.E. (1988) Neuron 1, 85^96.
[8] Nicholls, J.G. (1987) Sinauer, Sunderland, MA.
[9] von Bernhardi, R. and Muller, K.J. (1995) J. Neurobiol. 27, 353^
366.
[10] Emes, R., Wang, W.-Z. and Blackshaw, S.E. (2002) J. Physiol.
539P, 108P.
[11] Blackshaw, S. (1994) Prog. Neurobiol. 42, 333^338.
[12] Korneev, S., Fedorov, A., Collins, R., Blackshaw, S.E. and Da-
vies, J.A. (1997) Invert. Neurosci. 3, 185^192.
[13] Bannatyne, B.A., Blackshaw, S.E. and McGregor, M. (1989)
J. Exp. Biol. 143, 419^434.
[14] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular
Cloning, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY.
[15] Altschul, S.F., Madden, T.L., Scha¡er, A.A., Zhang, J., Zhang,
Z., Miller, W. and Lipman, D.J. (1997) Nucleic Acids Res. 25,
3389^3402.
[16] Appel, R.D., Bairoch, A. and Hochstrasser, D.F. (1994) Trends
Biochem. Sci. 19, 258^260.
[17] Letunic, I., Goodstadt, L., Dickens, N.J., Doerks, T., Schultz, J.,
Mott, R., Ciccarelli, F., Copley, R.R., Ponting, C.P. and Bork, P.
(2002) Nucleic Acids Res. 30, 242^244.
[18] Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) Nucleic
Acids Res. 22, 4673^4680.
[19] Perriere, G. and Gouy, M. (1996) Biochimie 78, 364^369.
[20] Goodstadt, L. and Ponting, C.P. (2001) Bioinformatics 17, 845^
846.
[21] Garcia-Barcelo, M., Tsui, S.K., Chim, S.S., Fung, K.P., Lee,
C.Y. and Waye, M.M. (1998) Genomics 47, 419^422.
FEBS 26834 19-12-02 Cyaan Magenta Geel Zwart
R.D. Emes et al./FEBS Letters 533 (2003) 124^128 127
[22] Birkenmeier, E.H. and Gordon, J.I. (1986) Proc. Natl. Acad. Sci.
USA 83, 2516^2520.
[23] Tsui, S.K., Yam, N.Y., Lee, C.Y. and Waye, M.M. (1994) Bio-
chem. Biophys. Res. Commun. 205, 497^505.
[24] Wang, X., Lee, G., Liebhaber, S.A. and Cooke, N.E. (1992)
J. Biol. Chem. 267, 9176^9184.
[25] Pfuhl, M., Winder, S.J. and Pastore, A. (1994) EMBO J. 13,
1782^1789.
[26] Weiskirchen, R., Erdel, M., Utermann, G. and Bister, K. (1997)
Genomics 44, 83^93.
[27] Yet, S.F., Folta, S.C., Jain, M.K., Hsieh, C.M., Maemura, K.,
Layne, M.D., Zhang, D., Marria, P.B., Yoshizumi, M., Chin,
M.T., Perrella, M.A. and Lee, M.E. (1998) J. Biol. Chem. 273,
10530^10537.
[28] Wood, V., Gwilliam, R., Rajandream, M.A., Lyne, M., Lyne, R.,
Stewart, A., Sgouros, J., Peat, N., Hayles, J., Baker, S., Basham,
D., Bowman, S., Brooks, K., Brown, D., Brown, S., Chilling-
worth, T., Churcher, C., Collins, M., Connor, R., Cronin, A.,
Davis, P., Feltwell, T., Fraser, A., Gentles, S., Goble, A., Ham-
lin, N., Harris, D., Hidalgo, J., Hodgson, G., Holroyd, S.,
Hornsby, T., Howarth, S., Huckle, E.J., Hunt, S., Jagels, K.,
James, K., Jones, L., Jones, M., Leather, S., McDonald, S.,
McLean, J., Mooney, P., Moule, S., Mungall, K., Murphy, L.,
Niblett, D., Odell, C., Oliver, K., O’Neil, S., Pearson, D., Quail,
M.A., Rabbinowitsch, E., Rutherford, K., Rutter, S., Saunders,
D., Seeger, K., Sharp, S., Skelton, J., Simmonds, M., Squares,
R., Squares, S., Stevens, K., Taylor, K., Taylor, R.G., Tivey, A.,
Walsh, S., Warren, T., Whitehead, S., Woodward, J., Volckaert,
G., Aert, R., Robben, J., Grymonprez, B., Weltjens, I., Van-
streels, E., Rieger, M., Schafer, M., Muller-Auer, S., Gabel, C.,
Fuchs, M., Fritzc, C., Holzer, E., Moestl, D., Hilbert, H., Bor-
zym, K., Langer, I., Beck, A., Lehrach, H., Reinhardt, R., Pohl,
T.M., Eger, P., Zimmermann, W., Wedler, H., Wambutt, R.,
Purnelle, B., Go¡eau, A., Cadieu, E., Dreano, S., Gloux, S.,
Lelaure, V., Mottier, S., Galibert, F., Aves, S.J., Xiang, Z.,
Hunt, C., Moore, K., Hurst, S.M., Lucas, M., Rochet, M., Gail-
lardin, C., Tallada, V.A., Garzon, A., Thode, G., Daga, R.R.,
Cruzado, L., Jimenez, J., Sanchez, M., del Rey, F., Benito, J.,
Dominguez, A., Revuelta, J.L., Moreno, S., Armstrong, J., Fors-
burg, S.L., Cerrutti, L., Lowe, T., McCombie, W.R., Paulsen, I.,
Potashkin, J., Shpakovski, G.V., Ussery, D., Barrell, B.G. and
Nurse, P. (2002) Nature 415, 871^880.
[29] Perez-Alvarado, G.C., Kosa, J.L., Louis, H.A., Beckerle, M.C.,
Winge, D.R. and Summers, M.F. (1996) J. Mol. Biol. 257, 153^
174.
[30] Freyd, G., Kim, S.K. and Horvitz, H.R. (1990) Nature 344, 876^
879.
[31] Karlsson, O., Thor, S., Norberg, T., Ohlsson, H. and Edlund, T.
(1990) Nature 344, 879^882.
[32] Way, J.C. and Chal¢e, M. (1988) Cell 54, 5^16.
[33] Dawid, I.B., Breen, J.J. and Toyama, R. (1998) Trends Genet.
14, 156^162.
[34] Shirasaki, R. and Pfa¡, S.L. (2002) Annu. Rev. Neurosci. 25,
251^281.
[35] Schmeichel, K.L. and Beckerle, M.C. (1997) Mol. Biol. Cell 8,
219^230.
[36] Schmeichel, K.L. and Beckerle, M.C. (1994) Cell 79, 211^219.
[37] Bach, I. (2000) Mech. Dev. 91, 5^17.
[38] Khoo, C., Blanchard, R.K., Sullivan, V.K. and Cousins, R.J.
(1997) Protein Exp. Purif. 9, 379^387.
[39] Lanningham-Foster, L., Green, C.L., Langkamp-Henken, B.,
Davis, B.A., Nguyen, K.T., Bender, B.S. and Cousins, R.J.
(2002) Am. J. Physiol. Endocrinol. Metab. 282, E1197^E1203.
[40] Cousins, R.J. and Lanningham-Foster, L. (2000) J. Infect. Dis.
182 (Suppl 1), S81^S84.
[41] Levenson, C.W., Shay, N.F., Lee-Ambrose, L.M. and Cousins,
R.J. (1993) Proc. Natl. Acad. Sci. USA 90, 712^715.
[42] Tlaskalova-Hogenova, H., Tuckova, L., Lodinova-Zadnikova,
R., Stepankova, R., Cukrowska, B., Funda, D.P., Striz, I., Ko-
zakova, H., Trebichavsky, I., Sokol, D., Rehakova, Z., Sinkora,
J., Fundova, P., Horakova, D., Jelinkova, L. and Sanchez, D.
(2002) Int. Arch. Allergy Immunol. 128, 77^89.
[43] Beck, G. (1998) Front. Biosci. 3, d559^d569.
[44] Beck, G., O’Brien, R.F. and Habicht, G.S. (1989) Bioessays 11,
62^67.
[45] Beck, G. and Habicht, G.S. (1991) Immunol. Today 12, 180^
183.
[46] Beschin, A., Bilej, M., Torreele, E. and De Baetselier, P. (2001)
Cell. Mol. Life Sci. 58, 801^814.
[47] Beschin, A., Bilej, M., Brys, L., Torreele, E., Lucas, R., Magez,
S. and De Baetselier, P. (1999) Nature 400, 627^628.
[48] Cooper, E.L. (1996) Prog. Mol. Subcell. Biol. 15, 10^45.
[49] Cooper, E.L., Kauschke, E. and Cossarizza, A. (2002) Bioessays
24, 319^333.
[50] de Eguileor, M., Tettamanti, G., Grimaldi, A., Boselli, A., Scari,
G., Valvassori, R., Cooper, E.L. and Lanzavecchia, G. (1999)
J. Invertebr. Pathol. 74, 14^28.
[51] Schwartz, M. (2001) Prog. Neurobiol. 65, 489^496.
[52] Gimsa, U., Wolf, S.A., Haas, D., Bechmann, I. and Nitsch, R.
(2001) J. Neuroimmunol. 119, 73^80.
FEBS 26834 19-12-02 Cyaan Magenta Geel Zwart
R.D. Emes et al./FEBS Letters 533 (2003) 124^128128
